Company Filing History:
Years Active: 2006
Title: Michele Bennet Kinrade: Innovator in Melanin Concentrating Hormone Research
Introduction
Michele Bennet Kinrade is an esteemed inventor based in Northford, Connecticut, who has made significant contributions to the field of biochemistry through her innovative research on melanin concentrating hormone receptors. With a total of two patents to her name, Kinrade's work stands at the intersection of science and health, particularly in developing therapeutic solutions for conditions associated with MCH receptor activation.
Latest Patents
Kinrade's latest patents include groundbreaking developments in isolated polynucleotides. The first patent focuses on isolating polynucleotides encoding monkey and canine Melanin Concentrating Hormone (MCH) Type 2 receptors, along with chimeric polypeptides. These innovations include vectors and cells for the recombinant expression of such MCH receptor polypeptides. The MCH receptor polynucleotides and polypeptides are anticipated to play a vital role in identifying agents specifically interacting with MCH receptors, which can be crucial for therapies targeted at both humans and animals suffering from conditions linked to MCH receptor activation.
Her second patent centers on the isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors and related chimeric polypeptides. Similar to her previous work, this patent includes the vectors and cells necessary for recombinant expression of MCH1R polypeptides. The compounds derived from this research are aimed at identifying interactions with MCH receptors, offering potential therapeutic pathways for afflictions connected with MCH receptor activation in both humans and animals.
Career Highlights
Kinrade’s professional journey is marked by her role at Neurogen Corporation, where she engages in innovative research that translates into real-world applications. Her co-workers include notable scientists like Robbin M Brodbeck and Stephen M Waters, with whom she collaborates to push the boundaries of current understanding in her field. The work environment at Neurogen fosters a culture of innovation that allows Kinrade to thrive as a pioneer in her research.
Collaborations
Collaboration is a key aspect of Kinrade's career. Working with colleagues such as Robbin M Brodbeck and Stephen M Waters, she has contributed to a dynamic research environment that emphasizes the sharing of ideas and expertise. These collaborations have not only enhanced her research capabilities but have also led to significant advancements in the understanding of melanin concentrating hormone receptors and their potential therapeutic applications.
Conclusion
Michele Bennet Kinrade exemplifies the role of an innovative inventor in the biochemistry domain. With her impactful patents focused on melanin concentrating hormone receptors, she continues to advance research that can lead to transformative therapies for a range of conditions. Kinrade's work at Neurogen Corporation is a testament to her dedication and contribution to science, paving the way for future discoveries in the field.